Efficacy of inhaled rhDNase for acute asthma in childhood
Completed
- Conditions
- Acute AsthmaRespiratoryAsthma
- Registration Number
- ISRCTN81874766
- Lead Sponsor
- Erasmus Medical Centre (Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Children, aged 2 - 18 years, with acute asthma who require at least two doses of bronchodilators at the Emergency Department.
Exclusion Criteria
1. Dyspnoea due to other causes than asthma
2. Patients with a concurrent chronic pulmonary disease, such as cystic fibrosis (CF), bronchopulmonary dysplasia (BPD)
3. Patients with a symptomatic cardial or neuromuscular disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in asthma score 1 hour after intervention.
- Secondary Outcome Measures
Name Time Method 1. Need for hospital admission<br>2. Duration of hospital admission<br>3. Asthma score at 2, 6, 12 and 24 hours after intervention<br>4. Heart rate, respiratory rate and oxygen saturation <br>5. Need for additional oxygen<br>6. Number of bronchodilators<br>7. Doctor?s visit or readmission and use of rescue bronchodilator aerosol therapy following 72 hours after discharge from EMD<br>8. Cost-consequence analysis